These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2121833)

  • 81. Expression of avian urokinase and tissue-type plasminogen activator messenger ribonucleic acid during follicle development and atresia.
    Johnson AL; Bridgham JT; Anthony RV
    Biol Reprod; 1997 Mar; 56(3):581-8. PubMed ID: 9047000
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Tissue plasminogen activator binding to mouse cerebellar granule neurons.
    Verrall S; Seeds NW
    J Neurosci Res; 1988; 21(2-4):420-5. PubMed ID: 3145983
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y; Hayashi Y; Imai Y; Itoh H
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Tissue factor and thrombomodulin expression on keratinocytes as coagulation/anti-coagulation cofactor and differentiation marker.
    Mizutani H; Ohyanagi S; Nouchi N; Inachi S; Shimizu M
    Australas J Dermatol; 1996 May; 37 Suppl 1():S48-9. PubMed ID: 8713017
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Secretion of urokinase and tissue-plasminogen activator by epidermal cells in the presence of psoriatic fibroblast-conditioned medium.
    Horiuchi Y; Marshall JM; Cederholm-Williams SA; Ryan TJ
    Acta Derm Venereol; 1992 Nov; 72(6):401-2. PubMed ID: 1362828
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann.
    Reinartz J; Näher H; Mai H; Kramer MD
    Arch Dermatol Res; 1993; 284(8):432-9. PubMed ID: 7682051
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Lesional psoriatic epidermis displays reduced neurofibromin immunoreactivity.
    Peltonen J; Karvonen SL; Ylä-Outinen H; Hirvonen O; Karvonen J
    J Invest Dermatol; 1995 Nov; 105(5):664-7. PubMed ID: 7594640
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Differential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system.
    Chen CS; Lyons-Giordano B; Lazarus GS; Jensen PJ
    J Cell Sci; 1993 Sep; 106 ( Pt 1)():45-53. PubMed ID: 8270642
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Increased serum interleukin-15 levels in bullous skin diseases: correlation with disease intensity.
    D'Auria L; Bonifati C; Cordiali-Fei P; Leone G; Picardo M; Pietravalle M; Giacalone B; Ameglio F
    Arch Dermatol Res; 1999 Jun; 291(6):354-6. PubMed ID: 10421062
    [No Abstract]   [Full Text] [Related]  

  • 91. Lesional upregulation of SLURP1 immunostaining parallels disease severity in psoriasis vulgaris patients.
    Assaf M; Salah E
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1329-1337. PubMed ID: 30395407
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator.
    Gualandris A; Jones TE; Strickland S; Tsirka SE
    J Neurosci; 1996 Apr; 16(7):2220-5. PubMed ID: 8601802
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Localization of immuno-analogues of erythrocyte protein 4.1 and spectrin in epidermis of psoriasis vulgaris.
    Shimizu T; Takakuwa Y; Koizumi H; Ishibashi T; Ohkawara A
    Histochem Cell Biol; 1995 May; 103(5):363-8. PubMed ID: 7641068
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A case of herpetiform pemphigus mimicking bullous pemphigoid after using secukinumab and successfully treated with sulfasalazine.
    Wang R; Wang M
    J Dermatol; 2023 Dec; 50(12):1625-1628. PubMed ID: 37641883
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Up-regulation of elafin/SKALP gene expression in psoriatic epidermis.
    Nonomura K; Yamanishi K; Yasuno H; Nara K; Hirose S
    J Invest Dermatol; 1994 Jul; 103(1):88-91. PubMed ID: 8027586
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Identification of mRNA-rich keratinocytes in the basal/suprabasal layers of psoriatic skin.
    Yokota K; Matsue H; Shibaki A; Kawashima T; Kobayashi H; Ohkawara A
    J Dermatol; 1996 Dec; 23(12):858-62. PubMed ID: 9037916
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Calcium-independent increases in pericellular plasminogen activator activity in pemphigus vulgaris.
    Crameri FM; Suter MM
    Exp Dermatol; 1993 Dec; 2(6):239-46. PubMed ID: 8162344
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Role of tissue-type plasminogen activator in salicylic acid-induced sloughing of human corn tissue.
    Heda GD; Roberts LK
    J Am Podiatr Med Assoc; 2008; 98(5):345-52. PubMed ID: 18820035
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cyclophilin content of normal and psoriatic epidermis.
    Griffiths CE; Fisher GJ; Harding MW; Elder JT; Voorhees JJ
    J Invest Dermatol; 1990 Apr; 94(4):436-40. PubMed ID: 2179418
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Tissue plasminogen activator gene expression in multiple sclerosis brain tissue.
    Akenami FO; Sirén V; Wessman M; Koskiniemi M; Vaheri A
    J Neurol Sci; 1999 May; 165(1):71-6. PubMed ID: 10426151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.